Effective IMT Starts With a Feasible Training Protocol and Identification of Clinical Relevant Outcome Parameters.

Autor: Seijger CGW; Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. Electronic address: c.g.w.seijger@umcg.nl., Nieuwenhuis J; Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands., van Engelen BGM; Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Nijmegen, Radboudumc, Nijmegen, The Netherlands., Wijkstra PJ; Department of Pulmonary Diseases and Home Mechanical Ventilation, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.

Publikováno v: Archivos de bronconeumologia [Arch Bronconeumol] 2024 May; Vol. 60 (5), pp. 326. Date of Electronic Publication: 2024 Feb 01.

Acceptability of automatic referrals to supportive and palliative care by patients living with advanced lung cancer: qualitative interviews and a co-design process.

Autor: Ahmed S; Alberta SPOR SUPPORT Unit, Patient Engagement Team, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada. sadahmed@ucalgary.ca.; Department of Community Health Sciences, University of Calgary, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada. sadahmed@ucalgary.ca., Simon J; Department of Community Health Sciences, University of Calgary, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada.; Division of Palliative Medicine, Department of Oncology, Cumming School of Medicine University of Calgary, Calgary, AB, Canada., Biondo P; Division of Palliative Medicine, Department of Oncology, Cumming School of Medicine University of Calgary, Calgary, AB, Canada., Slobogian V; Palliative and End of Life Care, Alberta Health Services, Calgary Zone, Calgary, Canada., Shirt L; Palliative and End of Life Care, Alberta Health Services, Calgary Zone, Calgary, Canada., King S; Department of Community Health Sciences, University of Calgary, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada., Paolucci A; Department of Community Health Sciences, University of Calgary, 3280 Hospital Dr NW, Calgary, AB, T2N 4Z6, Canada., Pabani A; Department of Oncology, Cumming School of Medicine University of Calgary, Calgary, AB, Canada., Hao D; Department of Oncology, Cumming School of Medicine University of Calgary, Calgary, AB, Canada., Bossio E; Patient and Family Advisor, Alberta Health Services, Calgary, AB, Canada., Cross R; Patient and Family Advisor, Alberta Health Services, Calgary, AB, Canada., Monds T; Patient and Family Advisor, Alberta Health Services, Calgary, AB, Canada., Nieuwenhuis J; Patient and Family Advisor, Alberta Health Services, Calgary, AB, Canada., Sinnarajah A; Division of Palliative Medicine, Department of Oncology, Cumming School of Medicine University of Calgary, Calgary, AB, Canada.; Division of Palliative Medicine, Department of Medicine, Queen's University, Kingston, ON, Canada.

Publikováno v: Research involvement and engagement [Res Involv Engagem] 2024 Apr 02; Vol. 10 (1), pp. 36. Date of Electronic Publication: 2024 Apr 02.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Posttranslational modification of microtubules by the MATCAP detyrosinase.

Autor: Landskron L; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Bak J; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Adamopoulos A; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Kaplani K; Department of Physiology, School of Medicine, University of Patras, 26504 Patras, Greece., Moraiti M; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., van den Hengel LG; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Song JY; Experimental Animal Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Bleijerveld OB; Proteomics Facility, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Nieuwenhuis J; Division of Biochemistry, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands., Heidebrecht T; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Henneman L; Transgenic Core Facility, Mouse Clinic for Cancer and Aging (MCCA), Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Moutin MJ; Université Grenoble Alpes, INSERM, U1216, CNRS, Grenoble Institut Neurosciences, 38000 Grenoble, France., Barisic M; Cell Division and Cytoskeleton, Danish Cancer Society Research Center (DCRC), 2100 Copenhagen, Denmark.; Department of Cellular and Molecular Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark., Taraviras S; Department of Physiology, School of Medicine, University of Patras, 26504 Patras, Greece., Perrakis A; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Brummelkamp TR; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.

Publikováno v: Science (New York, N.Y.) [Science] 2022 May 20; Vol. 376 (6595), pp. eabn6020. Date of Electronic Publication: 2022 May 20.